Cargando…
“Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety” [Response To Letter]
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560067/ https://www.ncbi.nlm.nih.gov/pubmed/34737590 http://dx.doi.org/10.2147/IDR.S344230 |
| _version_ | 1784592870048530432 |
|---|---|
| author | Mascellino, Maria Teresa Di Timoteo, Federica De Angelis, Massimiliano Oliva, Alessandra |
| author_facet | Mascellino, Maria Teresa Di Timoteo, Federica De Angelis, Massimiliano Oliva, Alessandra |
| author_sort | Mascellino, Maria Teresa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8560067 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85600672021-11-03 “Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety” [Response To Letter] Mascellino, Maria Teresa Di Timoteo, Federica De Angelis, Massimiliano Oliva, Alessandra Infect Drug Resist Response to Letter Dove 2021-10-28 /pmc/articles/PMC8560067/ /pubmed/34737590 http://dx.doi.org/10.2147/IDR.S344230 Text en © 2021 Mascellino et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Response to Letter Mascellino, Maria Teresa Di Timoteo, Federica De Angelis, Massimiliano Oliva, Alessandra “Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety” [Response To Letter] |
| title | “Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety” [Response To Letter] |
| title_full | “Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety” [Response To Letter] |
| title_fullStr | “Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety” [Response To Letter] |
| title_full_unstemmed | “Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety” [Response To Letter] |
| title_short | “Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety” [Response To Letter] |
| title_sort | “overview of the main anti-sars-cov-2 vaccines: mechanism of action, efficacy and safety” [response to letter] |
| topic | Response to Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560067/ https://www.ncbi.nlm.nih.gov/pubmed/34737590 http://dx.doi.org/10.2147/IDR.S344230 |
| work_keys_str_mv | AT mascellinomariateresa overviewofthemainantisarscov2vaccinesmechanismofactionefficacyandsafetyresponsetoletter AT ditimoteofederica overviewofthemainantisarscov2vaccinesmechanismofactionefficacyandsafetyresponsetoletter AT deangelismassimiliano overviewofthemainantisarscov2vaccinesmechanismofactionefficacyandsafetyresponsetoletter AT olivaalessandra overviewofthemainantisarscov2vaccinesmechanismofactionefficacyandsafetyresponsetoletter |